Position in BMRN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$208,448
-$121,685 QoQ
Shares Held
3,690
-33.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,301,919 | $269,139,417 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,302,493 | $126,967,017 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
259,468 | $48,593,167 | |
| 4 | ASND |
Ascendis Pharma A/S
|
171,447 | $45,728,343 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
1,072,830 | $41,518,521 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,081,421 | $38,271,489 | |
| 7 | FBRX |
Forte Biosciences, Inc.
|
1,439,697 | $30,593,561 | |
| 8 | ERAS |
Erasca, Inc.
|
1,308,455 | $23,970,895 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $208,448 | 3,690 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $330,133 | 5,555 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,283,591 | 23,700 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,572,526 | 28,607 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,036,083 | 28,803 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,700,435 | 25,870 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,867,816 | 26,573 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,430,052 | 29,516 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,723,261 | 31,180 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,219,367 | 33,389 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,617,239 | 40,882 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,125,707 | 47,597 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,925,431 | 132,923 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $7,516,064 | 72,626 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,279,412 | 38,686 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $5,917,249 | 71,404 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,467,494 | 122,795 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,070,347 | 215,850 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,157,451 | 40,852 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,183,319 | 38,151 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,298,524 | 30,440 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $39,145,692 | 446,410 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $28,898,455 | 379,843 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $152,153,580 | 1,233,611 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,521,591 | 18,007 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||